Cytokinetics, Incorporated
PublicCytokinetics, Incorporated is now publicly traded
The data on this page reflects Cytokinetics, Incorporated's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Angel
Apr 11, 2022
Total Funding Raised
$3M
Company Overview
Cytokinetics, Incorporated operates in Biotech and is based in South San Francisco, California. It has raised $3M.
Cytokinetics, Incorporated is a biopharmaceutical company that discovers, develops, and commercializes muscle activators and inhibitors to treat cardiovascular and neuromuscular diseases.
Sector
Biotech
AI Layer
Non-AI
Cytokinetics, Incorporated Comparables
Compare Cytokinetics, Incorporated with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kardigan | 74% | |
| Thryv Therapeutics | 61% | |
| Septal Solutions, Inc. | 57% |
For institutional investors. Book with your work email.
Cytokinetics, Incorporated Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cytokinetics, Incorporated Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.